Issue |
Med Buccale Chir Buccale
Volume 23, Number 3, October 2017
|
|
---|---|---|
Page(s) | 164 - 168 | |
Section | Cas clinique et revue de la littérature / Up-to date review and case report | |
DOI | https://doi.org/10.1051/mbcb/2017009 | |
Published online | 27 October 2017 |
Up-to Date Review And Case Report
Ameloblastic fibrosarcoma of the mandible: case report and literature review
1
Maxillofacial Surgery and Stomatology Department, CHU Hôtel Dieu,
1 place Alexis Ricordeau,
44093
Nantes, France
2
Odontology Department, CHU Hôtel Dieu,
1 place Alexis Ricordeau,
44093
Nantes, France
3
Maxillofacial Surgery and Stomatology Department, Pole Santé Sud,
28 rue de Guetteloup,
72000
Le Mans, France
* Correspondence: docteur.guiol@gmail.com
Received:
20
January
2017
Accepted:
27
April
2017
Introduction: Ameloblastic fibrosarcoma is a rare malignant odontogenic tumor. Over 50% reported cases have histological evidence of ameloblastic fibroma at the same site. The mortality rate of the tumor is 19% and its recurrence rate is 37%, which mandates a total resection along with long-term follow-up. Observation: We present the case of a 14-year-old male diagnosed with ameloblastic fibrosarcoma, who underwent multiple stages of treatments and was followed up over 8 years. The initial management consisted of a total tumor resection with chemoradiotherapy. Then, for bone, soft, mucosal, and dental restoration after resection, mandibular reconstruction with a fibula free flap, onlay iliac graft, iliac graft fixation, facial lipofilling treatments (two), vestibular deepening procedures (two), and implant-supported dental prosthesis were performed. Comments and conclusion: This is the first case reported in the literature for the global management of mandibular ameloblastic fibrosarcoma, from oncological treatment to functional and aesthetic long-term rehabilitation.
Key words: ameloblastic fibrosarcoma / facial reconstruction / dental implant
© The authors, 2017
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.